Modified Nucleosides
(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Quick view. (R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine is a structurally defined N6-substituted adenosine for research-use modified-nucleoside chemistry. CAS 96392-15-3. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine is classified as n6-substituted purine nucleoside (Formula C19H21N5O4; molecular weight 383.40).
(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine — A structurally defined N6-substituted adenosine for research-use modified-nucleoside chemistry.
For (R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- PD 117519
- CI 947
- N-[(1R)-Indan-1-yl]adenosine
Useful catalog search terms
- CAS 96392-15-3
Physicochemical data
| PubChem CID | 13424663 |
|---|---|
| InChIKey | FSKMJUWPFLDDRS-BYMDKACISA-N |
| Modification | R-configured indan-1-yl substituent at adenosine N6 |
| InChI | InChI=1S/C19H21N5O4/c25-7-13-15(26)16(27)19(28-13)24-9-22-14-17(20-8-21-18(14)24)23-12-6-5-10-3-1-2-4-11(10)12/h1-4,8-9,12-13,15-16,19,25-27H,5-7H2,(H,20,21,23)/t12-,13-,15-,16-,19-/m1/s1 |
| SMILES | C1CC2=CC=CC=C2[C@@H]1NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
BX-MN-0201Xylo-inosine
Modified Nucleosides · CAS: 10517-16-5
Frequently asked questions
Can the package size for (R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0719 and CAS 96392-15-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.